Proteomics International Partners with inVentiv Health Clinical
Proteomics International Partners with inVentiv Health Clinical
Proteomics International, a pretomics laboratory, has signed a collaborative agreement with inVentiv Health Clinical, provider of global research and bioanalytical services, with the intention of helping streamline the process from characterization to clinical trials.
Proteomics International's structural characterization and QC testing of proposed and referenced products with an advanced suite of scientific instrumentation complement inVentiv Health’s array of bioanalytical capabilities from clinical development through commercialization in support of biosimilar development.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025